publication date: Mar. 8, 2019
FDA Oncology Center of Excellence publishes research contract opportunities
The FDA Oncology Center of Excellence seeks white papers to award contracts for oncology regulatory science research through a Broad Agency Announcement, FDABAA-19-00123.
Research areas are described in the BAA document, but specific OCE interests include analysis of symptoms, physical function, immunotherapy biomarkers, non-clinical studies to evaluate new targeted therapies in children, real-world data endpoints, and external controls for pediatric studies.
Submit quad charts and whitepapers to FDABAA@fda.hhs.gov by March 30.
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.